APA

Tao J. J., Cangemi N. A., Makker V., Cadoo K. A., Liu J. F., Rasco D. W., Navarro W. H., Haqq C. M. & Hyman D. M. (20190925). First-in-Human Phase I Study of the Activin A Inhibitor, STM 434, in Patients with Granulosa Cell Ovarian Cancer and Other Advanced Solid Tumors. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Chicago

Tao Jessica J, Cangemi Nicholas A, Makker Vicky, Cadoo Karen A, Liu Joyce F, Rasco Drew W, Navarro Willis H, Haqq Christopher M and Hyman David M. 20190925. First-in-Human Phase I Study of the Activin A Inhibitor, STM 434, in Patients with Granulosa Cell Ovarian Cancer and Other Advanced Solid Tumors. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Harvard

Tao J. J., Cangemi N. A., Makker V., Cadoo K. A., Liu J. F., Rasco D. W., Navarro W. H., Haqq C. M. and Hyman D. M. (20190925). First-in-Human Phase I Study of the Activin A Inhibitor, STM 434, in Patients with Granulosa Cell Ovarian Cancer and Other Advanced Solid Tumors. : Clinical cancer research : an official journal of the American Association for Cancer Research.

MLA

Tao Jessica J, Cangemi Nicholas A, Makker Vicky, Cadoo Karen A, Liu Joyce F, Rasco Drew W, Navarro Willis H, Haqq Christopher M and Hyman David M. First-in-Human Phase I Study of the Activin A Inhibitor, STM 434, in Patients with Granulosa Cell Ovarian Cancer and Other Advanced Solid Tumors. : Clinical cancer research : an official journal of the American Association for Cancer Research. 20190925.